07/01/2026
SVI researchers Associate Professor Andrew Deans and Dr Sarah Henrikus have joined a national effort to develop targeted treatments for a group of aggressive cancers.
The $5 million funding from the National Health and Medical Research Council (NHMRC) Synergy Grant Scheme marks one of the largest coordinated investments yet in this area.
Professor Hilda Pickett at Children's Medical Research Institute (CMRI) leads the program, which is administered through the University of Sydney and delivered in partnership with CMRI, SVI and the University of Wollongong.
The team is targeting treatment-resistant cancers that activate the Alternative Lengthening of Telomeres (ALT) mechanism and make up about 10% of all cancers. These cancers are known to be fast-moving and difficult to treat.
Find out more: https://www.svi.edu.au/news-events/svi-joins-national-effort-to-develop-targeted-treatments-for-aggressive-cancers/